Nutra Pharma Corp.
NPHC · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2,044 | $14,465 | $7,929 | $2,355 |
| - Cash | $0 | $91 | -$143 | -$217 |
| + Debt | $8,552 | $8,195 | $5,039 | $8,477 |
| Enterprise Value | $10,596 | $22,570 | $13,111 | $11,049 |
| Revenue | $438 | $98 | $52 | $104 |
| % Growth | 348.4% | 88.3% | -50.3% | – |
| Gross Profit | $249 | $8 | $15 | $35 |
| % Margin | 56.8% | 8.7% | 28.7% | 33.3% |
| EBITDA | -$1,885 | -$12,536 | -$366 | -$6,252 |
| % Margin | -430% | -12,827% | -704.6% | -5,988.9% |
| Net Income | $8,177 | -$13,096 | -$769 | -$6,591 |
| % Margin | 1,865.7% | -13,399% | -1,482.1% | -6,314.1% |
| EPS Diluted | 0 | -0.002 | -0 | -0 |
| % Growth | 122.2% | -1,700% | 75% | – |
| Operating Cash Flow | -$762 | -$1,744 | -$878 | -$744 |
| Capital Expenditures | -$58 | -$39 | -$6 | $0 |
| Free Cash Flow | -$820 | -$1,784 | -$884 | -$744 |